triumph 1 trial retatrutide ⭐️topline results from TRIUMPH-1, a Phase 3 clinical evaluating #retatrutide, an investigational GIP / GLP-1 / glucagon triple hormone receptor agonist, in adults with obesity or “overweight” Retatrutide produces up to 30.3%

Hes Conner Mertens, Patient Advocate and Community Outreach manager at Global Healthy Living Foundation

Some researchers push as high as 2.0 grams per kilogram, though diminishing returns set in beyond 1.6 for most people

GLP-1 agonists and other incretin mimetics have been generating a consistent flow of headlines in traditional media, occupying an increasing share of voice in social media, and spreading through word of mouth like wildfire across certain affluent social circles

However, it also did not significantly increase levels of the protective adipokine adiponectin, an effect which was uniquely observed with the Kampo formula KBG ( The role of VE in cytokine modulation during NAFLD is complex and context-dependent

The LR3 modification extends its half-life, allowing for prolonged activity and enhanced effectiveness.IGF-1 LR3 works by stimulating muscle protein synthesis, promoting lean muscle growth, improving recovery, and supporting tissue repair

(STOP 1 and 2 trials)